Negotiation between the Parties. The parties shall first attempt to resolve any controversy that arises from this Agreement, or claim for breach of the Agreement, by good faith negotiations, first between their respective business development representatives and then, if necessary, between senior representatives for the Parties.
Appears in 5 contracts
Sources: Collaboration Agreement (Tg Therapeutics, Inc.), Collaboration Agreement (Checkpoint Therapeutics, Inc.), Collaboration Agreement (Checkpoint Therapeutics, Inc.)
Negotiation between the Parties. The parties shall first attempt to resolve any controversy that arises from this Agreement, or claim for breach of the Agreement, by good faith negotiations, first between their respective business development representatives and then, if necessary, between senior representatives for the Partiesparties, such as the Senior Vice- President for Research or President of DFCI and the CEO or President of CTI.
Appears in 3 contracts
Sources: License Agreement (Checkpoint Therapeutics, Inc.), License Agreement (Checkpoint Therapeutics, Inc.), License Agreement (Checkpoint Therapeutics, Inc.)
Negotiation between the Parties. The parties shall first attempt to resolve any controversy that arises from this Agreement, or claim for breach of the Agreement, by good faith negotiations, first between their respective business development representatives and then, if necessary, between senior representatives for the Partiesparties, such as the Sr. Vice President for Research or President of DFCI or the President of LICENSEE.
Appears in 2 contracts
Sources: License Agreement (Fibrogen Inc), License Agreement (Fibrogen Inc)
Negotiation between the Parties. The parties shall first attempt to resolve any controversy that arises from this Agreement, or claim for breach of the Agreement, by good faith negotiations, first between their respective business development representatives and then, if necessary, between senior representatives for the Partiesparties, such as the Sr. Vice President for Research or President of DFCI and the President of Licensee.
Appears in 2 contracts
Sources: Exclusive License Agreement, Exclusive License Agreement (Aveo Pharmaceuticals Inc)
Negotiation between the Parties. The parties shall first attempt to resolve any controversy that arises from this Agreement, or claim for breach of the Agreement, by good faith negotiations, first between their respective business development representatives and then, if necessary, between senior representatives for the Partiesparties, such as the Vice President, Research & Academic Affairs of MEEI and the President of Licensee.
Appears in 1 contract
Sources: Exclusive License Agreement (Aldeyra Therapeutics, Inc.)
Negotiation between the Parties. The parties shall first attempt to resolve any controversy that arises from this Agreement, or claim for breach of the Agreement, by good faith negotiations, first between their respective business development representatives and then, if necessary, between senior representatives for the Partiesparties, such as an Officer of Massachusetts Eye and Ear (or a designee to be appointed) and the President of Licensee.
Appears in 1 contract
Negotiation between the Parties. The parties shall first attempt to resolve any controversy that arises from this Agreement, or claim for breach of the Agreement, by good faith negotiations, first between their respective business development representatives and then, if necessary, between senior representatives for the Partiesparties, such as the Senior Vice-President for Research or President of DFCI and the CEO or President of Licensee.
Appears in 1 contract
Sources: License Agreement (Transgenomic Inc)
Negotiation between the Parties. The parties shall first attempt to resolve any controversy or dispute that arises from or under this Agreement, or any claim for a breach of the Agreement, by good faith negotiationsnegotiations during a [***] day period, first between their respective business development representatives and then, if necessary, between senior representatives for the Partiesparties, such as the Vice President, Research & Academic Affairs of MEE and the President of Licensee.
Appears in 1 contract
Sources: Exclusive License Agreement (Selecta Biosciences Inc)
Negotiation between the Parties. The parties shall first attempt to resolve any controversy that arises from this Agreement, or claim for breach of the Agreement, by good faith negotiations, first between their respective business development representatives and then, if necessary, between senior representatives for the Partiesparties, such as the Sr. Vice President for Research or President of DFCI and the CEO or President of Licensee.
Appears in 1 contract